30 Day Major Bleeding: PCI Cohort Number at risk Bivalirudin Heparin + GPIIb/IIIa Major Bleeding (Non-CABG) (%) Time in Days 8.6% 5.1% HR [95%CI] = 0.58 [0.44, 0.76] P< HR [95%CI] = 0.58 [0.44, 0.76] P< Heparin + GPIIb/IIIa inhibitor (n=1662) Bivalirudin monotherapy (n=1678)
{}